Eureka 93 (OTC:LXLLF) Stock, Quote.Headers.trade-ideas

Eureka 93 Inc is a Canada based company involved in hemp cultivation and CBD extraction operations in North America. The product offerings of the company include Wholesale CBD Products, Full Plant Extract and Isolate Powder.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AACAY

AAWW

ABBV

ABMD

ACGBF

ACRGF

ADMP

AERI

AGTK

AIBGY

ALKM

ALNA

ALSWF

AMAG

ANGI

APGMF

APNHY

APOP

ARCH

ARLO

ARLP

ARREF

ASRT

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATHOF

ATRA

ATVK

AVNS

AWLCF

AXGN

AXVEF

AZRX

AZZUF

BAFYY

BBCP

BBVA

BBVXF

BCDA

BCEFF

BCEL

BCYC

BDVSY

BEDU

BFIN

BHKLY

BICEF

BIDU

BIOAF

BIREF

BJRI

BKKLY

BKRIF

BKRIY

BLCM

BLMN

BLRX

BNDSF

BNEFF

BPAQF

BPFH

BRKMY

BRTX

BrightSphere Investment Group plc Ordinary Shares

BSIG

BTHE

BUDZ

BWFG

BXEFF

BZLFY

CADE

CAIXY

CAKE

CALX

CARB

CARCY

CARG

CARS

Stocks That Fell Through 52-Week Lows Wednesday

Cannabis

Topics

LXLLF

Montana-Based Grower And Processor Vitality Quickly Gathering Hemp Market Share

Eureka 93 Inc

he program, which covers drilling activities in calendar year 2025, requires a capital commitment from NOG expected not to exceed $160 million for a 15% working interest.
&nbsp;

Northern Oil And Gas Enters Joint Development Program With Existing Appalachian Operator; Adds Accretive Natural Gas Development In Appalachia With Strong Visibility And Surety Of Development

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) reported quarterly sales of $11.555 which missed the analyst consensus estimate of $11.995 million by 100.00 percent. This is a 100.00 percent decrease over sales of $11.946 million the same period last year.

Earnings

Earnings Misses

ELVA

Electrovaya Q4 Sales $11.555 Miss $11.995M Estimate

RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) reported quarterly earnings of $2.48 per share which missed the analyst consensus estimate of $2.65 by 6.42 percent. The company reported quarterly sales of $811.732 million which missed the analyst consensus estimate of $812.163 million by 0.05 percent. This is a 8.05 percent increase over sales of $751.225 million the same period last year.

RH Q3 2024 Adj. EPS $2.48 Misses $2.65 Estimate, Sales $811.732M Miss $812.163M Estimate

Company elects not to advance BBI-825 into Part 2 portion of STARMAP clinical trial
Third ecDTx program advancing, with plans for development candidate nomination by mid-2025
Operating runway extended into 2027, through anticipated clinical readout for BBI-355 and key development milestones for third ecDTx program
Klaus Wagner, M.D., Ph.D., Chief Medical Officer, and Neil Abdollahian, Chief Business Officer, stepping down; James L. Freddo, M.D., to serve as Interim Chief Medical Officer
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=oijMiMQTwRGwC6I0-aG6kt58BIYCpIajcHP8RScswMheO8t03pJRilJ3dfDAgjMyWbx4EYk5KRPiImEL3_tu1A==">Boundless Bio</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLD#NASDAQ">BOLD</a>), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced updates to its portfolio of ecDNA directed therapy (ecDTx) programs and to its executive leadership team.

Biotech

Management

BOLD

Boundless Bio Announces Pipeline And Leadership Updates; Company Elects Not To Advance BBI-825 Into Part 2 Portion Of STARMAP Clinical Trial; Operating Runway Extended Into 2027

<h3>Gainers</h3>
<ul>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) stock increased by 15.8% to $0.86 during Thursday's pre-market session. The market value of their outstanding shares is at $11.9 million. </li>
<li>AYRO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYRO#NASDAQ">AYRO</a>) stock rose 15.68% to $0.92. The company's market cap stands at $6.2 million. </li>
<li>17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) shares increased by 10.96% to $1.79. The market value of their outstanding shares is at $13.8 million. The company's, Q3 earnings came out yesterday. </li>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) stock increased by 10.82% to $1.74. The company's market cap stands at $5.3 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) shares rose 8.74% to $2.86. The market value of their outstanding shares is at $28.2 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares moved upwards by 7.97% to $3.25. The company's market cap stands at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sacks Parente Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) stock declined by 77.1% to $0.32 during Thursday's pre-market session. </li>
<li>Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) stock fell 25.11% to $28.22. The market value of their outstanding shares is at $439.0 million. As per the press release, Q3 earnings came out today. </li>
<li>Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) shares decreased by 14.4% to $11.0. The company's market cap stands at $39.6 million. </li>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) stock decreased by 13.01% to $18.0. The market value of their outstanding shares is at $90.3 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock decreased by 10.48% to $1.88. The company's market cap stands at $36.9 million. </li>
<li>Barnes &amp; Noble Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) stock decreased by 6.23% to $12.2. The market value of their outstanding shares is at $332.8 million. As per the news, the Q2 earnings report came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARKR

AYRO

BNED

CPHC

CTHR

LOVE

SPGC

TRNR

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Palisade Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares rose 104.3% to $2.86 during Thursday's pre-market session. The company's market cap stands at $4.3 million. </li>
<li>Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) stock rose 57.02% to $3.91. The market value of their outstanding shares is at $300.5 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) stock rose 21.97% to $0.11. The company's market cap stands at $12.5 million. </li>
<li>Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) stock moved upwards by 17.16% to $0.83. The market value of their outstanding shares is at $189.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares increased by 16.52% to $13.4. The company's market cap stands at $440.5 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares moved upwards by 15.5% to $11.56. The market value of their outstanding shares is at $5.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) shares fell 72.9% to $18.6 during Thursday's pre-market session. The market value of their outstanding shares is at $753.4 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock decreased by 46.35% to $0.44. The company's market cap stands at $1.4 million. </li>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) stock declined by 45.98% to $0.09. </li>
<li>SHL Telemedicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLT#NASDAQ">SHLT</a>) shares declined by 21.35% to $2.69. The company's market cap stands at $44.0 million. </li>
<li>Telix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) shares declined by 17.57% to $13.0. The company's market cap stands at $4.3 billion. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock fell 10.77% to $1.16. The market value of their outstanding shares is at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APVO

AVGR

EVAX

GOSS

JUNS

KROS

PALI

SHLT

TFFP

TRVI

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) shares moved upwards by 75.4% to $0.43 during Thursday's pre-market session. The company's market cap stands at $8.5 million. </li>
<li>Liquidity Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) shares rose 19.99% to $30.9. The company's market cap stands at $943.4 million. The company's, Q4 earnings came out today. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock rose 17.1% to $3.97. The company's market cap stands at $61.5 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock moved upwards by 15.76% to $0.95. The company's market cap stands at $17.1 million. </li>
<li>Staffing 360 Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares increased by 13.52% to $2.35. The company's market cap stands at $3.5 million. </li>
<li>Tigo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYGO#NASDAQ">TYGO</a>) shares increased by 9.31% to $0.93. The market value of their outstanding shares is at $56.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock declined by 39.7% to $1.84 during Thursday's pre-market session. The company's market cap stands at $41.0 million. </li>
<li>FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAIN#NASDAQ">FTAIN</a>) stock declined by 14.13% to $22.0. </li>
<li>Chicago Rivet &amp; Machine (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVR#AMEX">CVR</a>) stock declined by 11.55% to $14.01. The market value of their outstanding shares is at $13.5 million. </li>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares decreased by 8.87% to $23.74. The company's market cap stands at $1.4 billion. </li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) stock declined by 8.34% to $1.32. The company's market cap stands at $62.7 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) stock decreased by 8.26% to $1.0. The market value of their outstanding shares is at $18.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BURU

FTAIN

GLXG

ILAG

LQDT

SFHG

SRFM

STAF

TPIC

TYGO

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) shares rose 51.3% to $1.74 during Thursday's pre-market session. The market value of their outstanding shares is at $59.0 million. </li>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) stock increased by 21.08% to $6.89. The market value of their outstanding shares is at $121.7 million. </li>
<li>AmpliTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) shares increased by 19.14% to $2.3. The market value of their outstanding shares is at $28.7 million. </li>
<li>Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) shares increased by 13.93% to $83.41. The company's market cap stands at $11.9 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) stock moved upwards by 13.07% to $3.2. The market value of their outstanding shares is at $86.3 million. </li>
<li>TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) shares increased by 11.79% to $28.33. The company's market cap stands at $2.8 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock declined by 16.2% to $0.22 during Thursday's pre-market session. The company's market cap stands at $43.7 million. </li>
<li>Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) stock decreased by 11.28% to $487.91. The market value of their outstanding shares is at $214.7 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares decreased by 9.9% to $6.65. The company's market cap stands at $1.8 billion. </li>
<li>LeddarTech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) shares declined by 7.74% to $1.67. The company's market cap stands at $49.1 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock decreased by 6.38% to $3.23. The company's market cap stands at $1.8 million. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) stock decreased by 6.0% to $0.94. The company's market cap stands at $12.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADBE

AMPG

CIEN

IVAC

LAES

LDTC

RGTI

TTMI

XTKG

ZENA

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

WIIM

Inovio Pharmaceuticals shares are trading lower after the company announced a proposed public offering with terms or size not yet disclosed.

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) reported quarterly sales of $44.60 million which missed the analyst consensus estimate of $45.06 million by 1.02 percent.

Electrovaya FY Sales $44.60M Miss $45.06M Estimate

Washington Trust&nbsp;Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WASH#NASDAQ">WASH</a>) (the "Corporation"), parent company of The Washington Trust Company, of Westerly (the "Bank"), today announced it has commenced an underwritten public offering of $55,000,000 of the Corporation's common stock. The Corporation also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the offering. BofA Securities is serving as the sole book-running manager for the offering.

Offerings

WASH

Washington Trust Announces $55M Stock Offering

INOVIO Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public offering. All of the securities in the proposed offering will be sold by INOVIO. The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
Oppenheimer &amp; Co. Inc. and Citizens JMP are acting as joint book-running managers for the offering. Stephens Inc. is acting as lead manager for the offering.

INOVIO Announces Proposed Public Offering; No Size Or Amount Disclosed

EDIT

Editas Medicine shares are trading higher after the company announced plans to transition to an in vivo focus and initiated a reduction in headcount, aiming to eliminate approximately 65% of its workforce over the next six months.

Editas Medicine Initiates Cost Savings Measures And Reduction In Headcount To Align Workforce And Resources To In Vivo Pipeline, Extending Cash Runway Into Q2 2027

Editas Medicine Says Ending Development Of Reni-Cel After Extensive Search Did Not Yield A Commercial Partner

Ascendis Pharma A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) today announced that the U.S. Food &amp; Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) in adult growth hormone deficiency (GHD) for TransCon hGH (lonapegsomatropin-tcgd; marketed as SKYTROFA&#xAE; for pediatric GHD). The FDA set a Prescription Drug User Fee Act (PDUFA) goal date of July 27, 2025.

ASND

Ascendis Pharma Announces FDA Accepts Co's Supplemental Biologics License Application For TransCon hGH For The Treatment Of Adults With Growth Hormone Deficiency

Editas Medicine  Plans Transition To An In Vivo Company;  Initiates Reduction In Headcount That Will Eliminate Approximately 65% Of Its Workforce Over Next Six Months

Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) has outperformed the market over the past 20 years by 1.59% on an annualized basis producing an average annual return of 10.0%. Currently, Automatic Data Processing has a market capitalization of $122.00 billion. 
Buying $1000 In ADP: If an investor had bought $1000 of ADP stock 20 years ago, it would be worth $6,734.59 today based on a price of $299.42 for ADP at the time of writing.
<h3>Automatic Data Processing's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734037234_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

<a href="https://patentcenter.uspto.gov/applications/17309952/ifw/docs">https://patentcenter.uspto.gov/applications/17309952/ifw/docs</a>
<figure class="image"><img src="https://pbs.twimg.com/media/GeoFuBRbYAAU6fy?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GeoFuBSbQAAv6fV?format=jpg&amp;name=360x360" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GeoFuBRa0AAdLTR?format=jpg&amp;name=small" alt="Image" /></figure>

CANF

Can-Fite Biopharma Has Received A Notice Of Allowance For A US Patent Titled "AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT (FOR THE TREATMENT OF OBESITY)"

Macro Economic Events

Market Summary

Economics

AVGO

COST

Benzinga Market Summary: Indexes Close Lower On Worse-Than-Expected PPI Data, Broadcom And Costco To Report After The Close, Gold And Silver Drop

Eureka 93

Comments

Eureka 93

Eureka 93 (LXLLF) Forecast

Eureka 93 (OTC:LXLLF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga